Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 11Breast 4Lymphoid 2Genitourinary 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Endocrine 1

Conditions

Vision Disorders 1Pituitary Neoplasms 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diffusion Tensor Imaging × Endocrine × Clear all
NCT03591315 2018-07-23

Clinical Study of Structural and Functional Evaluation of the Visual Pathway

Xiangya Hospital of Central South University

Unknown
60 enrolled
Endocrine

Pituitary Neoplasms, Vision Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡